Centiva Capital’s Boston Scientific BSX Stock Holding History

Centiva Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-40,000	Closed	-$2.74M	–	2085
2024 Q1	$2.74M	Sell	40,000 -20,000	-33%	-$1.29M	0.07%	229
2023 Q4	$3.47M	Buy	60,000 +40,000	+200%	+$2.14M	0.08%	229
2023 Q3	$1.06M	Sell	20,000 -15,600	-44%	-$818K	0.02%	610
2023 Q2	$1.93M	Hold	35,600	–	–	0.04%	397
2023 Q1	$1.78M	Buy	+35,600	New	+$1.68M	0.04%	430

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Centiva Capital's BSX Position: Q1 2026 in Review

Centiva Capital opened a new position in Boston Scientific (BSX) in Q1 2026: 36,251 shares worth $2.27M. The stake represents 0.02% of the portfolio and ranks #401 among its holdings. This is a return to the name: Centiva Capital previously reported a position in BSX as recently as Q2 2025.

Centiva Capital first reported a position in BSX in Q3 2019 and has held it in 14 quarters since. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Centiva Capital held 36,251 shares of Boston Scientific worth $2.27M as of Q1 2026.
Boston Scientific was a new Centiva Capital position in Q1 2026.
Boston Scientific made up 0.02% of Centiva Capital's portfolio in Q1 2026, its #401 holding.
Centiva Capital first reported a position in Boston Scientific in Q3 2019 and has held it in 14 quarters since.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.